All Imaavy articles

News

J&J biologic Imaavy achieves EU first in generalised myasthenia gravis

2025-12-03T13:36:06Z

The monoclonal antibody becomes the first neonatal Fc receptor (FcRn) blocker to be approved in Europe for the condition.